Urology · Bethpage, NY
NPI
1740243674
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
4230 Hempstead Tpke
Bethpage, NY, 11714
Phone (516) 796-2222
Groups this clinician bills Medicare through
Medicare paid, 2024
$770K
54,786 services
Medicare patients, 2024
1,214
Average age 76
Drug cost, 2024
$1.2M
4,428 prescriptions
Company payments, 2025
$2,619
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul A Peller was code J1071 (injection, testosterone cypionate, 1 mg), 26,401 times for 17 patients. In total Paul A Peller billed 54,786 services in 100 codes, and Medicare paid $770K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-04-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 26,401 | 17 | $0.00 | $6.23 |
| J9155 Injection, degarelix, 1 mg | Office | 5,120 | 14 | $3.32 | $17K |
| J0897 Injection, denosumab, 1 mg | Office | 4,140 | 14 | $20.73 | $86K |
| 81002 Clinical Chemistry | Office | 1,862 | 1,067 | $3.39 | $6,311 |
| 51798 Ultrasound - Nonspecific | Office | 1,733 | 1,054 | $11.01 | $19K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,556 | 975 | $14.76 | $23K |
| 99214 Office E&M - Established | Office | 1,139 | 777 | $116.94 | $133K |
| 36415 Venipuncture Blood Collection | Office | 1,026 | 688 | $8.58 | $8,798 |
| 51741 Test - Miscellaneous | Office | 739 | 513 | $13.00 | $9,606 |
| 84153 Clinical Chemistry | Office | 720 | 539 | $18.02 | $13K |
| 99213 Office E&M - Established | Office | 616 | 507 | $77.53 | $48K |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 513 | 457 | $55.76 | $29K |
| 80053 Clinical Chemistry | Office | 505 | 412 | $10.35 | $5,227 |
| 99459 Office/Outpatient Services | Office | 285 | 212 | $22.68 | $6,465 |
| P9612 Catheterization for collection of specimen, single patient, all places of service | Office | 281 | 200 | $8.65 | $2,431 |
By year: 2022 $635K for 49,060 services; 2023 $740K for 51,915 services; 2024 $770K for 54,786 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 1,862 | 1,067 | $3.39 | $6,311 |
| 36415 Venipuncture Blood Collection | 1,026 | 688 | $8.58 | $8,798 |
| 84153 Clinical Chemistry | 720 | 539 | $18.02 | $13K |
| 80053 Clinical Chemistry | 505 | 412 | $10.35 | $5,227 |
| P9612 Catheterization for collection of specimen, single patient, all places of service | 281 | 200 | $8.65 | $2,431 |
| 84403 Clinical Chemistry | 230 | 185 | $25.29 | $5,817 |
| 87086 Bacterial Culture | 187 | 152 | $7.91 | $1,479 |
| 87186 General Laboratory | 120 | 53 | $8.48 | $1,017 |
| 80048 Clinical Chemistry | 75 | 69 | $8.29 | $622 |
| 87088 Bacterial Culture | 64 | 53 | $7.93 | $508 |
Medicare prescription drug claims, 2024
In 2024, the drug Paul A Peller prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,035 prescriptions and refills. In total Paul A Peller wrote 4,428 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,035 | 2,871 | 363 | $20K |
| Finasteride Generic | 577 | 1,611 | 183 | $8,430 |
| Methenamine Hippurate Generic | 554 | 1,481 | 191 | $47K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 234 | 694 | 79 | $5,378 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 175 | 454 | 55 | $5,002 |
| Gemtesa Vibegron | 156 | 353 | 43 | $163K |
| Testosterone Cypionate Generic | 134 | 172 | 23 | $3,227 |
| Xyosted Testosterone Enanthate | 133 | 143 | 18 | $83K |
| Ciprofloxacin Hcl Generic | 107 | 107 | 90 | $544 |
| Cefpodoxime Proxetil Generic | 107 | 107 | 93 | $3,599 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 100 | 291 | 40 | $16K |
| Allopurinol Generic | 87 | 261 | 29 | $980 |
| Myrbetriq Mirabegron | 65 | 149 | 25 | $64K |
| Solifenacin Succinate Generic | 61 | 179 | 26 | $5,906 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 60 | 60 | 33 | $1,000 |
Brand drugs: - claims; generic drugs: 3,896 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul A Peller $2,619 ($2,619 in general payments such as food, travel and fees) from 25 companies. The largest payer was Accord Healthcare, Inc. with $456.
| Company | Payments | Amount |
|---|---|---|
| Accord Healthcare, Inc. | 1 | $456 |
| Janssen Biotech, Inc. JNJ | 8 | $332 |
| Teleflex LLC TFX | 5 | $285 |
| Sumitomo Pharma America, Inc. 4506.T | 12 | $272 |
| Dendreon Pharmaceuticals LLC | 4 | $110 |
| Verity Pharmaceuticals Inc. | 4 | $95.85 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $95.74 |
| Abbvie Inc. ABBV | 4 | $93.77 |
| Olympus America Inc. | 4 | $88.49 |
| Urogen Pharma, Inc. URGN | 3 | $75.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.